Non-Coding RNA is a prestigious open-access journal published by MDPI, based in Switzerland, dedicated to the significant and rapidly evolving field of non-coding RNA research. Established in 2015, this journal has quickly become an essential resource for researchers and professionals, showcasing innovative studies and breakthroughs related to the functions and mechanisms of non-coding RNAs in various biological processes. With an impressive Q1 ranking in Biochemistry and strong rankings in Genetics and Molecular Biology, Non-Coding RNA consistently reflects the highest standards of academic publishing. The journal provides comprehensive access options, granting researchers worldwide the ability to disseminate and access high-quality research without subscription barriers. As the landscape of genomics and molecular discoveries continues to expand, the journal aims to foster interdisciplinary exchanges and collaborations, making it a vital platform for advancing knowledge and innovation in this critical area of biological science.

Briefings in Functional Genomics, published by Oxford University Press, serves as a crucial academic resource in the fields of biochemistry, genetics, and molecular biology. With an ISSN of 2041-2649 and an E-ISSN of 2041-2657, this esteemed journal explores innovative research and developments in functional genomics, with a commitment to advancing our understanding of genetic processes and their implications in health and disease. Ranking in the Q2 quartile for both Biochemistry and Genetics, and occupying a prominent Q1 status in the domain of interdisciplinary Medicine, the journal is positioned as a leading platform for researchers seeking to disseminate their findings to a global audience. Although it does not currently offer open access options, its accessibility through institutional subscriptions and its esteemed impact factor underscore its importance in the research community. Covering converging topics from 2010 to 2024, Briefings in Functional Genomics not only keeps pace with the rapidly evolving landscape of genomics but also stimulates collaboration and dialogue among scientists and industry professionals alike, making it an indispensable tool for researchers, practitioners, and students eager to engage with cutting-edge genomic science.

Genetics Research, published by HINDAWI LTD, is a distinguished open access journal that has been at the forefront of genetic studies since its inception in 1960. With the transition to open access in 2019, this journal has expanded its accessibility, fostering knowledge dissemination across the global scientific community. Operating out of the United Kingdom, it provides a platform for innovative research in the fields of genetics and molecular biology, encompassing a broad range of topics that are highly relevant to medical sciences. As of 2023, it holds a Q4 classification in Genetics and a Q3 classification in miscellaneous Medicine, reflecting its ongoing commitment to scholarly excellence amidst shifting academic landscapes. While the journal's H-index remains unlisted, its indexed ranking within Scopus, with a rank of #325/328 in the Genetics category highlights the challenges ligated to its niche audience. Nevertheless, it serves as a crucial resource for researchers, professionals, and students eager to contribute to and stay informed on the latest genetic research trends and breakthroughs.

PLoS Genetics, published by the PUBLIC LIBRARY SCIENCE, is a leading open-access journal dedicated to advancing the field of genetics, molecular biology, and related disciplines. With its ISSN of 1553-7404, this esteemed journal has been offering unrestricted access to its content since 2005, fostering a global community of researchers, professionals, and students. Situated in the United States, its contributions can be found at 1160 Battery Street, Ste 100, San Francisco, CA 94111. As of 2023, PLoS Genetics proudly holds a Q1 ranking in multiple categories including Cancer Research, Ecology, Evolution, Behavior and Systematics, Genetics, and Molecular Biology, underscoring its impact in these vital scientific areas. The journal's commitment to disseminating high-quality research is reflected in its impressive Scopus rankings, with notable positions in various fields of study, ensuring that it remains a crucial resource for cutting-edge research and innovation. By providing an open-access platform, PLoS Genetics not only enhances the visibility of genetic research but also encourages collaborations and the sharing of knowledge that can lead to significant breakthroughs in science.

MOLECULAR BIOLOGY, published by PLEIADES PUBLISHING INC, serves as a vital repository for the dissemination of innovative research within the fields of biochemistry, genetics, and molecular biology. With an ISSN of 0026-8933 and an E-ISSN of 1608-3245, this journal has been a mainstay in the scientific community since its inception, embracing its deep historical roots from 1971 to the present. Recognized for its qualitative contributions, MOLECULAR BIOLOGY is ranked in the Q3 quartile for Biophysics and Q4 for Structural Biology, placing it among select journals in its domain. Researchers and students alike benefit from its rigorous peer-reviewed articles, which focus on all aspects of molecular mechanisms and interactions. The journal's inclusion in prestigious databases underlines its commitment to academic excellence. The editorial board is dedicated to fostering the sharing of influential findings, making it an essential resource for advancing knowledge and innovation in molecular biology.

GENOME is a leading peer-reviewed journal published by Canadian Science Publishing, dedicated to advancing the field of genetics, biotechnology, and molecular biology. With a strong commitment to disseminating high-quality research, GENOME has earned a reputable spot in the academic community, boasting a Q2 classification in Biotechnology and Medicine (miscellaneous), and a Q3 rank in Genetics and Molecular Biology for 2023. The journal, identified by its ISSN 0831-2796 and E-ISSN 1480-3321, publishes innovative studies that span from 1987 to 2024, ensuring a rich historical context while addressing contemporary challenges in the field. Researchers and professionals are encouraged to contribute and engage with content that shapes the landscape of genetic research. Although the journal does not currently provide open access, it remains a vital resource for those committed to the exploration of genomic sciences, making it an essential read for both seasoned researchers and students alike.

Non-coding RNA Research, published by KEAI PUBLISHING LTD, is a leading open-access journal dedicated to advancing the field of non-coding RNA, a critical component in the landscape of molecular biology and genetics. Established in 2016, this journal aims to provide a platform for the dissemination of high-quality research focusing on the roles, mechanisms, and therapeutic potentials of non-coding RNAs in various biological processes and diseases. With impressive Scopus rankings placing it in the top quartile for both Biochemistry and Medical Biochemistry, as well as notable standings in Genetics and Molecular Biology, Non-coding RNA Research continues to attract contributions from globally recognized experts. The journal's commitment to open access ensures broad visibility and engagement with cutting-edge discoveries, thereby fostering an inclusive scientific dialogue that enhances understanding and innovation in this rapidly evolving field. For researchers and scholars, the opportunity to publish in a Q1 ranked journal not only validates their work but also enhances its impact, making Non-coding RNA Research an indispensable resource for anyone interested in the intricate workings of non-coding RNA.

GENOME BIOLOGY is a premier, peer-reviewed journal published by BMC, focusing on the rapidly evolving fields of genomics, molecular biology, and bioinformatics. Accessible as an Open Access journal since 2000, it aims to disseminate high-quality, cutting-edge research that contributes to our understanding of genome biology's intricate mechanisms. The journal boasts an impressive impact, ranking 8th in Agricultural and Biological Sciences and 9th in Biochemistry, Genetics and Molecular Biology, highlighting its significance among scholars, professionals, and students alike. With a commitment to facilitating the exchange of invaluable scientific knowledge, GENOME BIOLOGY provides an important platform for discussions on evolutionary biology, genetic systems, and cell biology, contributing to the advancement of these dynamic disciplines.

GENOMICS is a prestigious journal published by Academic Press Inc Elsevier Science, dedicated to advancing the field of genetic research and molecular biology. With an impressive impact factor, this journal is recognized for its rigorous peer-review process and high-quality publications that cover a wide range of topics within the genomics discipline. Operating from the United States, GENOMICS has established itself as a vital resource for researchers, professionals, and students alike, standing at Q2 in the Genetics category according to the latest rankings. With a rich history dating back to 1987 and convergence extending to 2024, the journal highlights cutting-edge discoveries and methodologies, ensuring that its readership remains at the forefront of genetic advancements. Although currently not an open-access journal, articles published within its pages are often accessible through various academic platforms, enhancing worldwide reach and dissemination. For those engaged in the fields of biochemistry, genetics, and molecular biology, GENOMICS serves as an indispensable platform for impactful research and collaborative initiatives.

The Journal of Gene Medicine, published by Wiley, stands as a pivotal resource in the field of gene therapy and molecular medicine, with a rich history of dissemination of impactful research since its inception in 1998. With an ISSN of 1099-498X and an E-ISSN of 1521-2254, this esteemed journal plays a crucial role in advancing our understanding of genetics and drug discovery, reflected in its impressive 2023 Scopus rankings where it holds a Q2 classification in Drug Discovery and Q3 in several genetics-related categories. The journal aims to facilitate the exchange of high-quality research findings that bridge the gap between laboratory and clinical applications, making it an essential platform for researchers, academics, and healthcare professionals committed to the forefront of genetic innovation. Although it does not currently offer open access options, its reputation for rigorous peer review ensures that all published work meets the highest academic standards, providing a reliable reference for scientific inquiry in the United States and beyond. As the field rapidly evolves, the Journal of Gene Medicine remains at the helm, guiding future discoveries with its influential publications and comprehensive insights.